{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T23:16:57Z","timestamp":1769555817114,"version":"3.49.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2006,10,1]],"date-time":"2006-10-01T00:00:00Z","timestamp":1159660800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2006,10]]},"DOI":"10.1016\/j.ijantimicag.2006.05.031","type":"journal-article","created":{"date-parts":[[2006,8,25]],"date-time":"2006-08-25T22:15:54Z","timestamp":1156544154000},"page":"340-344","source":"Crossref","is-referenced-by-count":16,"title":["Pharmacodynamic profiling of imipenem, meropenem and ertapenem against clinical isolates of extended-spectrum \u03b2-lactamase-producing Escherichia coli and Klebsiella spp. from Brazil"],"prefix":"10.1016","volume":"28","author":[{"given":"Carlos R.V.","family":"Kiffer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph L.","family":"Kuti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathryn J.","family":"Eagye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caio","family":"Mendes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David P.","family":"Nicolau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2006.05.031_bib1","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1128\/CMR.14.4.933-951.2001","article-title":"Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat","volume":"14","author":"Bradford","year":"2001","journal-title":"Clin Microbiol Rev"},{"issue":"Suppl. 4","key":"10.1016\/j.ijantimicag.2006.05.031_bib2","doi-asserted-by":"crossref","first-page":"S273","DOI":"10.1086\/430789","article-title":"Extended-spectrum beta-lactamases","volume":"41","author":"Turner","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2006.05.031_bib3","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.diagmicrobio.2005.10.001","article-title":"Prevalence and antimicrobial susceptibility data for extended-spectrum beta-lactamase- and AmpC-producing Enterobacteriaceae from the MYSTIC Program in Europe and the United States (1997\u20132004)","volume":"53","author":"Goossens","year":"2005","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2006.05.031_bib4","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1590\/S1413-86702005000300004","article-title":"Antimicrobial susceptibility of Gram-negative bacteria in Brazilian hospitals: the MYSTIC Program Brazil 2003","volume":"9","author":"Kiffer","year":"2005","journal-title":"Braz J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2006.05.031_bib5","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1055\/s-2003-37923","article-title":"Global epidemiology of antimicrobial resistance among community-acquired and nosocomial pathogens: a five-year summary from the SENTRY Antimicrobial Surveillance Program (1997\u20132001)","volume":"24","author":"Jones","year":"2003","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.ijantimicag.2006.05.031_bib6","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/00075198-200310000-00012","article-title":"Antimicrobial resistance among gram-negative organisms in the intensive care unit","volume":"9","author":"Clark","year":"2003","journal-title":"Curr Opin Crit Care"},{"key":"10.1016\/j.ijantimicag.2006.05.031_bib7","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1086\/313719","article-title":"Epidemiology of ciprofloxacin resistance and its relationship to extended-spectrum beta-lactamase production in Klebsiella pneumoniae isolates causing bacteremia","volume":"30","author":"Paterson","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2006.05.031_bib8","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1086\/322667","article-title":"Epidemiological investigation of fluoroquinolone resistance in infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae","volume":"33","author":"Lautenbach","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2006.05.031_bib9","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1093\/jac\/dkg237","article-title":"Efficacy of ertapenem in the treatment of serious infections caused by Enterobacteriaceae: analysis of pooled clinical trial data","volume":"51","author":"Gesser","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2006.05.031_bib10","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1128\/AAC.45.10.2831-2837.2001","article-title":"Activity of ertapenem (MK\u20130826) versus Enterobacteriaceae with potent beta-lactamases","volume":"45","author":"Livermore","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2006.05.031_bib11","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1128\/AAC.45.6.1860-1867.2001","article-title":"In vitro activities of ertapenem (MK\u20130826) against recent clinical bacteria collected in Europe and Australia","volume":"45","author":"Livermore","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2006.05.031_bib12","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1016\/j.clinthera.2004.11.009","article-title":"Pharmacodynamic modeling of carbapenems and fluoroquinolones against bacteria that produce extended-spectrum \u03b2-lactamases","volume":"26","author":"Moczygemba","year":"2004","journal-title":"Clin Ther"},{"key":"10.1016\/j.ijantimicag.2006.05.031_bib13","doi-asserted-by":"crossref","first-page":"3203","DOI":"10.1128\/AAC.48.8.3203-3206.2004","article-title":"Role of beta-lactamases and porins in resistance to ertapenem and other beta-lactams in Klebsiella pneumoniae","volume":"48","author":"Jacoby","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2006.05.031_bib14","unstructured":"Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Fifteenth Informational Supplement. Document M100-S15. Wayne, PA: CLSI; 2005."},{"key":"10.1016\/j.ijantimicag.2006.05.031_bib15","doi-asserted-by":"crossref","first-page":"3765","DOI":"10.1128\/AAC.48.10.3765-3772.2004","article-title":"Ertapenem pharmacokinetics and impact on intestinal microflora, in comparison to those of ceftriaxone, after multiple dosing in male and female volunteers","volume":"48","author":"Pletz","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2006.05.031_bib16","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1128\/AAC.48.7.2464-2470.2004","article-title":"Optimizing pharmacodynamic target attainment using the MYSTIC antibiogram: data collected in North America in 2002","volume":"48","author":"Kuti","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2006.05.031_bib17","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1093\/jac\/dki079","article-title":"Standardization of pharmacokinetic\/pharmacodynamic (PK\/PD) terminology for anti-infective drugs: an update","volume":"55","author":"Mouton","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2006.05.031_bib18","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1093\/jac\/dki117","article-title":"In vitro susceptibilities of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: the 2003 Study for Monitoring Antimicrobial Resistance Trends (SMART)","volume":"55","author":"Paterson","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2006.05.031_bib19","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1590\/S1413-86702005000100008","article-title":"Antimicrobial susceptibility in intensive care units: MYSTIC Program Brazil 2002","volume":"9","author":"Mendes","year":"2005","journal-title":"Braz J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2006.05.031_bib20","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1093\/jac\/dkg375","article-title":"Properties and potential of ertapenem","volume":"52","author":"Livermore","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2006.05.031_bib21","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1590\/S1413-86702004000100008","article-title":"Klebsiella pneumoniae with multiple antimicrobial resistance","volume":"8","author":"Mendes","year":"2004","journal-title":"Braz J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2006.05.031_bib22","unstructured":"Andrade SS, Silva RC, Cay\u00f4 R, Furtado G, Pignatari AC, Tufik S. Caracteriza\u00e7\u00e3o dos mecanismos de resist\u00eancia em Klebsiella pneumoniae resistente a carbapenems. In: 39th Congresso Brasileiro de Patologia Cl\u00ednica\/Medicina Laboratorial; 2005 September 17\u201320; S\u00e3o Paulo, Brazil (abstract P15)."}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857906002615?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857906002615?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,13]],"date-time":"2019-01-13T23:51:36Z","timestamp":1547423496000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857906002615"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,10]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,10]]}},"alternative-id":["S0924857906002615"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2006.05.031","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2006,10]]}}}